Skip to content

Kopin KOPN Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

L3Harris Technologies logo
L3Harris TechnologiesLHX
500M0.0%
Science Applications International Corporation logo
Science Applications International CorporationSAIC
MACOM Technology Solutions logo
MACOM Technology SolutionsMTSI
Booz Allen Hamilton logo
Booz Allen HamiltonBAH
Ducommun logo
DucommunDCO
Curtiss-Wright logo
Curtiss-WrightCW

Other financials

Income statement

See full
Revenue$10.6M+0.1%
Operating income-$6.0M-53.2%
Net income-$3.8M-20.5%
EPS (diluted)-$0.020.0%

Balance sheet

See full
Cash & equivalents$34.1M+123%
Total debt$1.3M-31.7%
Total equity$60.8M+194%
Total assets$102.4M+57.5%

Cash flow

See full
Operating cash flow-$810.7K+76.3%
CapEx$1.3M+160%
Free cash flow-$2.1M+46.0%

Valuation

See full
Market cap$702.29M+175%
Enterprise value$669.47M+177%
P/E356.9×
P/S17.9×+12.8×

Profitability

See full
Gross margin46.7%
Operating margin-30.3%+2.4pp
Net margin5%+2.7pp
FCF margin-38.6%+13.3pp

Returns & leverage

See full
Return on equity4.8%+2.5pp
Debt / equity-0.1×
Current ratio2.6×+1.2×

Where this comes from

Reported directly by Kopin in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Kopin’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kopin's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kopin's common stock, shares authorized (in shares)?
Kopin (KOPN) reported common stock, shares authorized (in shares) of $275M in Q1 2026.
How has Kopin's common stock, shares authorized (in shares) changed year-over-year?
Kopin's common stock, shares authorized (in shares) increased by 37.5% year-over-year, from $200M to $275M.
What is the long-term trend for Kopin's common stock, shares authorized (in shares)?
Over 5 years (2020 to 2025), Kopin's common stock, shares authorized (in shares) has grown at a 12.9% compound annual growth rate (CAGR), from $150M to $275M.